vs

Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Corning Inc. (GLW). Click either name above to swap in a different company.

Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $4.1B, roughly 1.3× Corning Inc.). Corning Inc. runs the higher net margin — 9.3% vs 7.9%, a 1.4% gap on every dollar of revenue. On growth, Corning Inc. posted the faster year-over-year revenue change (0.0% vs -0.3%).

Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.

Corning Incorporated is an American multinational technology company specializing in glass, ceramics, and related materials and technologies including advanced optics, primarily for industrial and scientific applications. Founded in 1851, the company was called Corning Glass Works for most of its history. Corning was known during the 20th century for its consumer product lines, such as including CorningWare and Visions Pyroceram-based cookware, Corelle Vitrelle tableware, and Pyrex glass bake...

FMS vs GLW — Head-to-Head

Bigger by revenue
FMS
FMS
1.3× larger
FMS
$5.5B
$4.1B
GLW
Growing faster (revenue YoY)
GLW
GLW
+0.3% gap
GLW
0.0%
-0.3%
FMS
Higher net margin
GLW
GLW
1.4% more per $
GLW
9.3%
7.9%
FMS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
FMS
FMS
GLW
GLW
Revenue
$5.5B
$4.1B
Net Profit
$434.2M
$387.0M
Gross Margin
27.4%
36.9%
Operating Margin
11.7%
15.4%
Net Margin
7.9%
9.3%
Revenue YoY
-0.3%
0.0%
Net Profit YoY
240.4%
-60.0%
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMS
FMS
GLW
GLW
Q1 26
$4.1B
Q4 25
$5.5B
$4.2B
Q3 25
$4.1B
Q2 25
$3.9B
Q1 25
$3.5B
Q4 24
$5.5B
$3.5B
Q3 24
$3.4B
Q2 24
$3.3B
Net Profit
FMS
FMS
GLW
GLW
Q1 26
$387.0M
Q4 25
$434.2M
$540.0M
Q3 25
$430.0M
Q2 25
$469.0M
Q1 25
$157.0M
Q4 24
$127.6M
$310.0M
Q3 24
$-117.0M
Q2 24
$104.0M
Gross Margin
FMS
FMS
GLW
GLW
Q1 26
36.9%
Q4 25
27.4%
35.5%
Q3 25
37.1%
Q2 25
36.0%
Q1 25
35.2%
Q4 24
25.0%
34.2%
Q3 24
33.5%
Q2 24
29.2%
Operating Margin
FMS
FMS
GLW
GLW
Q1 26
15.4%
Q4 25
11.7%
15.9%
Q3 25
14.4%
Q2 25
14.8%
Q1 25
12.9%
Q4 24
5.1%
11.2%
Q3 24
8.9%
Q2 24
5.7%
Net Margin
FMS
FMS
GLW
GLW
Q1 26
9.3%
Q4 25
7.9%
12.8%
Q3 25
10.5%
Q2 25
12.1%
Q1 25
4.5%
Q4 24
2.3%
8.9%
Q3 24
-3.5%
Q2 24
3.2%
EPS (diluted)
FMS
FMS
GLW
GLW
Q1 26
$0.43
Q4 25
$0.61
Q3 25
$0.50
Q2 25
$0.54
Q1 25
$0.18
Q4 24
$0.36
Q3 24
$-0.14
Q2 24
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMS
FMS
GLW
GLW
Cash + ST InvestmentsLiquidity on hand
$1.7B
$1.8M
Total DebtLower is stronger
$7.7M
Stockholders' EquityBook value
$15.4B
$12.3M
Total Assets
$33.5B
$31.3M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMS
FMS
GLW
GLW
Q1 26
$1.8M
Q4 25
$1.7B
$1.5B
Q3 25
Q2 25
Q1 25
Q4 24
$1.3B
$1.8B
Q3 24
Q2 24
Total Debt
FMS
FMS
GLW
GLW
Q1 26
$7.7M
Q4 25
$7.6B
Q3 25
$7.4B
Q2 25
$6.7B
Q1 25
$7.0B
Q4 24
$6.9B
Q3 24
$7.1B
Q2 24
$6.9B
Stockholders' Equity
FMS
FMS
GLW
GLW
Q1 26
$12.3M
Q4 25
$15.4B
$11.8B
Q3 25
$11.5B
Q2 25
$11.1B
Q1 25
$10.7B
Q4 24
$17.0B
$10.7B
Q3 24
$11.1B
Q2 24
$10.6B
Total Assets
FMS
FMS
GLW
GLW
Q1 26
$31.3M
Q4 25
$33.5B
$31.0B
Q3 25
$29.9B
Q2 25
$28.7B
Q1 25
$27.4B
Q4 24
$36.3B
$27.7B
Q3 24
$28.3B
Q2 24
$27.2B
Debt / Equity
FMS
FMS
GLW
GLW
Q1 26
0.62×
Q4 25
0.65×
Q3 25
0.64×
Q2 25
0.60×
Q1 25
0.65×
Q4 24
0.64×
Q3 24
0.64×
Q2 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMS
FMS
GLW
GLW
Operating Cash FlowLast quarter
$2.9B
$362.0M
Free Cash FlowOCF − Capex
$188.0M
FCF MarginFCF / Revenue
4.5%
Capex IntensityCapex / Revenue
8.0%
Cash ConversionOCF / Net Profit
6.67×
0.94×
TTM Free Cash FlowTrailing 4 quarters
$1.7B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMS
FMS
GLW
GLW
Q1 26
$362.0M
Q4 25
$2.9B
$1.1B
Q3 25
$784.0M
Q2 25
$708.0M
Q1 25
$151.0M
Q4 24
$2.6B
$623.0M
Q3 24
$699.0M
Q2 24
$521.0M
Free Cash Flow
FMS
FMS
GLW
GLW
Q1 26
$188.0M
Q4 25
$620.0M
Q3 25
$450.0M
Q2 25
$400.0M
Q1 25
$-57.0M
Q4 24
$369.0M
Q3 24
$482.0M
Q2 24
$279.0M
FCF Margin
FMS
FMS
GLW
GLW
Q1 26
4.5%
Q4 25
14.7%
Q3 25
11.0%
Q2 25
10.4%
Q1 25
-1.7%
Q4 24
10.5%
Q3 24
14.2%
Q2 24
8.6%
Capex Intensity
FMS
FMS
GLW
GLW
Q1 26
8.0%
Q4 25
10.2%
Q3 25
8.1%
Q2 25
8.0%
Q1 25
6.0%
Q4 24
7.3%
Q3 24
6.4%
Q2 24
7.4%
Cash Conversion
FMS
FMS
GLW
GLW
Q1 26
0.94×
Q4 25
6.67×
1.95×
Q3 25
1.82×
Q2 25
1.51×
Q1 25
0.96×
Q4 24
20.20×
2.01×
Q3 24
Q2 24
5.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons